Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BioGenerator Ventures is a venture capital firm located in St. Louis, Missouri, with a fund size of $50 million. The firm has invested in over 130 companies and has helped its portfolio raise a total of $2.8 billion. They focus on addressing significant challenges in human health and agriculture.
BioGenerator Ventures specializes in early-stage investments in life sciences, particularly in therapeutics, diagnostics, medical devices, research tools, agriculture, and healthcare. They often serve as the first professional capital for their portfolio companies and actively syndicate deals with global capital sources.
Notable companies in BioGenerator Ventures' portfolio include Geneoscopy, an RNA detection platform for colorectal cancer screening; Benson Hill, which went public in a $2 billion SPAC merger; MediBeacon, known for its fluorescent tracer agents; SentiAR, which uses augmented reality for treatment delivery; and Plastomics, focused on improving crop yields through chloroplast technology.
Submit your pitch through their form at biogeneratorventures.com or email info@biogeneratorventures.com with your deck.
Yes, BioGenerator Ventures often leads rounds, particularly in early-stage investments where they serve as the first professional capital.
The firm actively participates in follow-on investments to support the growth of its portfolio companies as they scale.
BioGenerator Ventures currently manages a fund size of $50 million, focusing on early-stage life sciences companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.